Allain_1997_Clin.Ther_19_4

Reference

Title : Drugs used in Alzheimer's disease and neuroplasticity - Allain_1997_Clin.Ther_19_4
Author(s) : Allain H , Bentue-Ferrer D , Gandon JM , Le Doze F , Belliard S
Ref : Clin Ther , 19 :4 , 1997
Abstract :

Drugs indicated for use in Alzheimer's disease (AD) must clinically improve the cognitive symptomatology of the disorder, although nonexclusively. From a neurochemical standpoint, these drugs must oppose the multiple processes recognized as stigmata of AD. In these two ways, so-called AD drugs may be considered substances modifying cerebral plasticity. Long-term evaluation of anticholinesterases and of tacrine, in particular, provides arguments in support of this initially purely biologic, theoretical approach. This concept of neuroplasticity applied to dementia may modify the traditional pharmaceutical drug development programs.

PubMedSearch : Allain_1997_Clin.Ther_19_4
PubMedID: 9083704

Related information

Citations formats

Allain H, Bentue-Ferrer D, Gandon JM, Le Doze F, Belliard S (1997)
Drugs used in Alzheimer's disease and neuroplasticity
Clin Ther 19 :4

Allain H, Bentue-Ferrer D, Gandon JM, Le Doze F, Belliard S (1997)
Clin Ther 19 :4